Published in Bull World Health Organ on January 01, 1991
Should measles be eradicated? BMJ (1998) 1.50
Effectiveness of measles vaccination and vitamin A treatment. Int J Epidemiol (2010) 1.45
Improving vaccination coverage in urban areas through a health communication campaign: the 1990 Philippine experience. Bull World Health Organ (1994) 1.33
Measles control in the United States: problems of the past and challenges for the future. Clin Microbiol Rev (1995) 0.91
Immunoglobulin G subclass profile of antimeasles response in vaccinated children and in adults with measles history. Clin Diagn Lab Immunol (2005) 0.91
Optimizing reactive responses to outbreaks of immunizing infections: balancing case management and vaccination. PLoS One (2012) 0.85
Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals. Clin Diagn Lab Immunol (2002) 0.84
Measles Elimination Activities in the Western Pacific Region: Experience from the Republic of Korea. J Korean Med Sci (2015) 0.83
Measles virus-specific immunoglobulin G isotype immune response in early and late infections. J Clin Microbiol (2001) 0.83
Recurring measles epidemic in Vietnam 2005-2009: implication for strengthened control strategies. Int J Biol Sci (2011) 0.79
Measles in England and Wales--I: An analysis of factors underlying seasonal patterns. Int J Epidemiol (1982) 5.16
Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps). Lancet (1952) 3.56
Measles in developing countries. Part II. The predicted impact of mass vaccination. Epidemiol Infect (1988) 2.31
A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol (1987) 2.13
Measles control efforts in urban Africa complicated by high incidence of measles in the first year of life. Am J Epidemiol (1988) 1.59
Malnutrition and overcrowding/intensive exposure in severe measles infection: review of community studies. Rev Infect Dis (1988) 1.43
Measles immunization research: a review. Bull World Health Organ (1989) 1.15
Measles control: so near and yet so far. Prog Med Virol (1985) 1.14
Measles control in Yaounde: justification of a one dose, nine month minimum age vaccination policy in tropical Africa. Lancet (1984) 1.14
Measles, mumps, and rubella vaccine: what coverage to block transmission? Lancet (1988) 0.95
Measles--United States, 1989 and first 20 weeks 1990. MMWR Morb Mortal Wkly Rep (1990) 0.92
Assessment of vaccination coverage, vaccination scar rates, and smallpox scarring in five areas of West Africa. Bull World Health Organ (1973) 12.31
Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. Bull World Health Organ (1982) 12.11
Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA (2000) 4.36
Impact of anti-vaccine movements on pertussis control: the untold story. Lancet (1998) 4.18
Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA (1985) 3.85
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA (1999) 3.77
Morbidity and mortality associated with the July 1980 heat wave in St Louis and Kansas City, Mo. JAMA (1982) 3.69
Does influenza vaccination prevent asthma exacerbations in children? J Pediatr (2001) 2.89
Clinical survey techniques to estimate prevalence and annual incidence of poliomyelitis in developing countries. Bull World Health Organ (1980) 2.86
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med (1998) 2.46
Projections of AIDS morbidity and mortality in San Francisco. JAMA (1990) 2.42
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet (1993) 2.24
Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis (1993) 2.21
Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA (1999) 2.09
Confounding in studies of adverse reactions to vaccines. Am J Epidemiol (1992) 2.06
Indications and contraindications for vaccines used in the Expanded Programme on Immunization. Bull World Health Organ (1984) 1.99
Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA (1996) 1.93
Risk factors for outbreaks of influenza in nursing homes. A case-control study. Am J Epidemiol (1986) 1.93
Strategies for the global eradication of poliomyelitis by the year 2000. N Engl J Med (1991) 1.92
The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med (2001) 1.84
Processes for obtaining nonmedical exemptions to state immunization laws. Am J Public Health (2001) 1.83
Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med (1994) 1.79
Expanded programme on immunization. World Health Stat Q (1988) 1.76
The case for global eradication of poliomyelitis. Bull World Health Organ (1987) 1.72
Cost-benefit analysis and immunization programmes in developing countries. Bull World Health Organ (1980) 1.58
Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis (1992) 1.55
Injection safety: a global challenge. Bull World Health Organ (1999) 1.52
The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health (1997) 1.50
Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child. Am J Epidemiol (1984) 1.47
Causes of low preschool immunization coverage in the United States. Annu Rev Public Health (1992) 1.45
Diphtheria in the United States, 1971-81. Am J Public Health (1985) 1.44
Human immunodeficiency virus infection and routine childhood immunisation. Lancet (1987) 1.42
Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes. Antimicrob Agents Chemother (1984) 1.42
Evaluation of telephoned computer-generated reminders to improve immunization coverage at inner-city clinics. Public Health Rep (1993) 1.40
Pertussis--a disease and a vaccine that are not going away. West J Med (1989) 1.35
Preparing for pandemic influenza: the need for enhanced surveillance. Emerg Infect Dis (1999) 1.32
Risk factors for community- and household-acquired pertussis during a large-scale outbreak in central Wisconsin. J Infect Dis (1988) 1.31
Current poliomyelitis immunization policy in the United States. Pediatr Ann (1990) 1.28
Alternative routes of measles immunization: a review. Biologicals (1997) 1.27
An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine (1999) 1.23
Autism, inflammatory bowel disease, and MMR vaccine. Lancet (1998) 1.20
Negative association between MMR and autism. Lancet (1999) 1.20
Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink Team. Vaccine (2000) 1.19
Advanced age a risk factor for illness temporally associated with yellow fever vaccination. Emerg Infect Dis (2001) 1.19
The complicated task of monitoring vaccine safety. Public Health Rep (1997) 1.19
The incidence of Kawasaki syndrome in West Coast health maintenance organizations. Pediatr Infect Dis J (2000) 1.17
Immunizing the children of the world: progress and prospects. Bull World Health Organ (1988) 1.17
A randomized controlled trial of influenza vaccine in the elderly. Scientific scrutiny and ethical responsibility. JAMA (1994) 1.17
Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J (2001) 1.17
Systemic and coronary hemodynamic effects of sodium nitroprusside. Am Heart J (1974) 1.16
Measles immunization research: a review. Bull World Health Organ (1989) 1.15
Use of influenza vaccine in nursing homes. J Am Geriatr Soc (1985) 1.14
Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination. Am J Epidemiol (2001) 1.13
The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med (1988) 1.12
Door-to-door canvassing for immunization program acceleration in Mozambique: achievements and costs. Int J Health Serv (1990) 1.12
Assessment and possible control of endemic measles in urban Nigeria. J Public Health Med (1995) 1.11
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol (1994) 1.09
Elective ilioinguinal lymph node irradiation. Int J Radiat Oncol Biol Phys (1984) 1.08
The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis (1997) 1.08
Kawasaki syndrome: association with the application of rug shampoo. Lancet (1982) 1.06
Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team. Pediatrics (1996) 1.06
Improving sexually transmitted disease health services for gays: a national prospective. Sex Transm Dis (1977) 1.05
Control of sexually transmitted diseases in the United States-A federal perspective. Br J Vener Dis (1977) 1.05
A randomized trial of the effectiveness of computer-generated telephone messages in increasing immunization visits among preschool children. Arch Pediatr Adolesc Med (1994) 1.04
Clinical efficacy of measles vaccine during the 1990 measles epidemic. Pediatr Infect Dis J (1991) 1.04
Addressing the challenges to immunization practice with an economic algorithm for vaccine selection. Vaccine (1998) 1.03
Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine (2001) 1.03
Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt. Bull World Health Organ (1995) 1.03
Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine. Int J Epidemiol (1993) 1.01
Cumulative incidence of childhood-onset IDDM is unaffected by pertussis immunization. Diabetes Care (1997) 1.01
Prevention of secondary transmission of pertussis in households with early use of erythromycin. Am J Dis Child (1992) 1.01
Outbreak of pyogenic abscesses after diphtheria and tetanus toxoids and pertussis vaccination. Pediatr Infect Dis J (1993) 1.00
Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Vaccine Safety Datalink Team. Pediatr Infect Dis J (1998) 1.00
Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group. J Infect Dis (1997) 0.99
Monitoring progress toward US preschool immunization goals. JAMA (1992) 0.99
Acute hemorrhagic conjunctivitis Investigation of a large-scale community outbreak in Dade County, Florida. JAMA (1983) 0.98
Vaccination levels and missed opportunities for measles vaccination: a record audit in a public pediatric clinic. Pediatrics (1992) 0.98
Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review. J Viral Hepat (2003) 0.97
Strategies for minimizing nosocomial measles transmission. Bull World Health Organ (1997) 0.97
Ensuring vaccine safety in immunization programmes--a WHO perspective. Vaccine (2001) 0.96
Venereal disease: a national health problem. Clin Obstet Gynecol (1975) 0.95
Respiratory diphtheria in the United States, 1980 through 1995. Am J Public Health (1998) 0.95
Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS). Pediatrics (2000) 0.95
Hospitalizations for measles, 1970-78. Am J Public Health (1982) 0.94
Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics (2001) 0.94
Outbreak of paralytic poliomyelitis in a highly immunized population in Jordan. J Infect Dis (1997) 0.93
Influenza vaccination and warfarin or theophylline toxicity in nursing-home residents. N Engl J Med (1983) 0.92
Clinical problems in measles case management. Ann Trop Paediatr (1996) 0.91
Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects. The Vaccine Safety Datalink Investigators. Ann N Y Acad Sci (1995) 0.90
Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine. Int J Epidemiol (1994) 0.89
Smallpox transmission in Southern Dahomey. A study of a village outbreak. Am J Epidemiol (1969) 0.88
Measuring vaccine efficacy from epidemics of acute infectious agents. Stat Med (1993) 0.87
[Distribution of 14C labeled at dioxopiperazine or methyl morpholine group of probimane by whole body autoradiography]. Zhongguo Yao Li Xue Bao (1993) 0.87
Clinical findings and results of treatment in an outbreak of acute hemorrhagic conjunctivitis in southern Florida. Am J Ophthalmol (1983) 0.87
Autism and measles-mumps-rubella vaccination: controversy laid to rest? CNS Drugs (2001) 0.87
Two-dose measles vaccination schedules. Bull World Health Organ (1993) 0.86
Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team. Arch Fam Med (2000) 0.86
Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group. Vaccine (2000) 0.86